FDA described the clinical evidence as inconclusive and preliminary and identified product-characterisation, aggregation, immunogenicity and safety uncertainties
But before we delve into the practicalities, it is absolutely crucial to state this clearly: This information is for guidance only and is NOT a substitute for professional medical training
If you experience severe abdominal pain, blood in your stool, or prolonged constipation lasting more than a few weeks, contact your healthcare provider
The primary mechanisms of action include: Enhanced insulin secretion : GLP-1 receptor agonists stimulate glucose-dependent insulin release from pancreatic beta cells, meaning insulin is released only when blood glucose levels are elevated, reducing hypoglycemia risk when used as monotherapy (though risk increases when combined with insulin or sulfonylureas)
A new generation of diabetes drugs known as GLP-1 receptor agonists (GLP-1s) include Novo Nordisks Ozempic (semaglutide), taken by some celebrities as a weight-loss aid, and Eli Lillys Trulicity (dulaglutide)
Participants began losing weight by the four-week mark, and this trend continued throughout the study period